| __timestamp | Geron Corporation | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 2999000 |
| Thursday, January 1, 2015 | 17793000 | 10393000 |
| Friday, January 1, 2016 | 18761000 | 15994000 |
| Sunday, January 1, 2017 | 19287000 | 26975000 |
| Monday, January 1, 2018 | 18707000 | 39509000 |
| Tuesday, January 1, 2019 | 20893000 | 48869000 |
| Wednesday, January 1, 2020 | 25678000 | 42510000 |
| Friday, January 1, 2021 | 29665000 | 46105000 |
| Saturday, January 1, 2022 | 43628000 | 50513000 |
| Sunday, January 1, 2023 | 69135000 | 51292000 |
Cracking the code
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Geron Corporation and Wave Life Sciences Ltd. have taken different paths in optimizing these costs. From 2014 to 2023, Geron Corporation's SG&A expenses surged by over 300%, peaking in 2023. In contrast, Wave Life Sciences Ltd. saw a more moderate increase of around 70% during the same period.
While Geron Corporation's expenses grew steadily, Wave Life Sciences Ltd. experienced a sharp rise between 2017 and 2019, with a 45% increase. This divergence highlights the strategic choices each company made in resource allocation. As the biotech industry continues to evolve, understanding these financial strategies offers valuable insights into corporate efficiency and market positioning.
Cost Management Insights: SG&A Expenses for Johnson & Johnson and Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of Bio-Techne Corporation and Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Geron Corporation
Selling, General, and Administrative Costs: Opthea Limited vs Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: Alpine Immune Sciences, Inc. vs Wave Life Sciences Ltd.
PTC Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Xenon Pharmaceuticals Inc. vs Geron Corporation
Selling, General, and Administrative Costs: Bausch Health Companies Inc. vs Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Vericel Corporation or Geron Corporation
Cost Management Insights: SG&A Expenses for HUTCHMED (China) Limited and Geron Corporation
Cost Management Insights: SG&A Expenses for Protagonist Therapeutics, Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for Geron Corporation and Dynavax Technologies Corporation